Mountain Lake Acquisition Corp. Units (MLACU) 10-K/A 2 Jun 21 2020 FY Annual report (amended) Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 30, 2021	Jun. 30, 2020
Document Information Line Items
Entity Registrant Name	Malacca Straits Acquisition Co Ltd
Document Type	10-K/A
Current Fiscal Year End Date	--12-31
Entity Public Float			$ 142,456,250
Amendment Flag	true
Amendment Description	References throughout this Amendment No. 1 to the Annual Report on Form 10-K to “we,” “us,” the “Company” or “our company” are to Malacca Straits Acquisition Company Limited, unless the context otherwise indicates.This Amendment No. 1 to the Annual Report on Form 10-K/A (this “Report”) amends our Annual Report on Form 10-K for the period ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 31, 2021 (the “Original Report”).On April 12, 2021, the staff of the SEC (the “SEC Staff”) issued a public statement (the “SEC Staff Statement”) entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”).” In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to warrants issued by SPACs may require the warrants to be classified as liabilities instead of equity on the SPAC’s balance sheet.Since their issuances on July 17, 2020 in connection with our initial public offering (the “IPO”) and on July 21, 2020 in connection with the exercise of underwriters’ over-allotment option and until the date of the restatements, our warrants were reflected as a component of equity instead of liabilities on our balance sheet and, based on our application of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”), our statement of operations did not include the subsequent non-cash changes in estimated fair value of the warrants. The views expressed in the SEC Staff Statement were not consistent with our historical interpretation of specific provisions within our warrant agreement, dated as of July 14, 2020 (the “warrant agreement”), and our application of ASC 815-40 to the warrant agreement. After discussion, evaluation and consultation with management, our audit committee concluded that our warrants should be presented as liabilities with subsequent fair value remeasurement.Prior to filing this Report, in consultation with our audit committee, we concluded that the Company’s (i) previously issued audited balance sheet dated as of July 17, 2020 which was related to its initial public offering; (ii) unaudited interim financial statements as of and for the three and nine months quarterly period ended September 30, 2020, as reported in the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 15, 2020; and (iii) audited financial statements as of December 31, 2020 and for the period January 1, 2020 (commencement of operations) through December 31, 2020 as reported in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2021 (collectively, the “Affected Periods”) should no longer be relied upon and should be restated and that the warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in our statement of operations each reporting period. On May 19, 2021, our audit committee authorized management to restate its audited financial statements for the period ended December 31, 2020 (the “restatement”).The change in accounting for the warrants reflected in the restatements did not have any impact on our liquidity, cash flows, revenues or costs of operating our business or other non-cash adjustments during the Affected Periods or during any other period for which financial information is included in this Report. Our cash and cash equivalents, investments held in the trust account, operating expenses or total cash flows from operations during the Affected Periods also were not affected.Items Amended in this ReportThis Report presents the Original Report, amended and restated with modifications necessary to reflect the restatements, but without any other amendments, modifications or updates. As such, this Report speaks only as of the date the Original Report was filed, and should be read in conjunction with our other SEC filings, including our SEC filings subsequent to the date of the Original Report.The following items have been amended to reflect the restatements:Part I, Item 1A. Risk FactorsPart II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of OperationsPart II, Item 8. Financial Statements and Supplementary DataPart II, Item 9A. Controls and ProceduresPart IV, Item 15. Exhibits, Financial Statement Schedules.In addition, our Chief Executive Officer and Chief Financial Officer have provided new certifications dated as of the date of this filing in connection with this Report (Exhibits 31.1, 31.2, 32.1 and 32.2).We have not amended our previously filed Current Report on Form 8-K filed on July 23, 2020 or our Quarterly Report on Form 10-Q filed on November 16, 2020 for the periods affected by the restatement. The financial information that has been previously filed or otherwise reported for these periods is superseded by the information in this Report, and the financial statements and related financial information contained in such previously filed reports should no longer be relied upon.
Entity Central Index Key	0001807594
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Entity File Number	001-39383
Entity Incorporation, State or Country Code	E9
Entity Interactive Data Current	Yes
Class A Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		14,375,000
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		3,593,750

Balance Sheet

Balance Sheet	Dec. 31, 2020USD ($)
ASSETS
Cash	$ 730,837
Prepaid expenses	75,844
Total Current Assets	806,681
Cash and marketable securities held in Trust Account	143,815,744
TOTAL ASSETS	144,622,425
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities- accrued expenses	81,485
Derivative warrant liabilities	12,186,260
Deferred underwriting fee payable	5,031,250
Total Liabilities	17,298,995
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 12,232,342 shares at $10.00 per share	122,323,420
Shareholders’ Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital	12,624,978
Accumulated deficit	(7,625,541)
Total Shareholders’ Equity	5,000,010
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	144,622,425
Class A Ordinary Shares
Shareholders’ Equity
Ordinary shares	214
Total Shareholders’ Equity	214
Class B Ordinary Shares
Shareholders’ Equity
Ordinary shares	359
Total Shareholders’ Equity	$ 359

Balance Sheet (Parentheticals)

Balance Sheet (Parentheticals)	Dec. 31, 2020$ / sharesshares
Preference shares,par value (in Dollars per share) | $ / shares	$ 0.0001
Preference shares, authorized	1,000,000
Preference shares, issued
Preference shares, outstanding
Class A Ordinary Shares
Ordinary shares subject to possible redemption	12,232,342
Ordinary shares subject to possible redemption, per share (in Dollars per share) | $ / shares	$ 10
Ordinary shares, par value (in Dollars per share) | $ / shares	$ 0.0001
Ordinary shares, authorized	200,000,000
Ordinary shares, issued	2,142,658
Ordinary shares, outstanding	2,142,658
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share) | $ / shares	$ 0.0001
Ordinary shares, authorized	20,000,000
Ordinary shares, issued	3,593,750
Ordinary shares, outstanding	3,593,750

Statement of Operations

Statement of Operations	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Income Statement [Abstract]
Formation and operating costs	$ 311,104
Loss from operations	(311,104)
Other income (expense):
Interest earned – bank	4
Interest earned on marketable securities held in Trust Account	65,744
Issuance costs related to warrant liability	(186,456)
Change in fair market value of derivative warrant liabilities	(7,193,729)
Net Loss	$ (7,625,541)
Weighted average shares outstanding of Class A redeemable ordinary shares (in Shares) | shares	14,330,357
Basic and diluted net income per share, Class A ordinary shares (in Dollars per share) | $ / shares	$ 0
Weighted average shares outstanding of Class B non-redeemable ordinary shares (in Shares) | shares	3,402,841
Basic and diluted net loss per share, Class B ordinary shares (in Dollars per share) | $ / shares	$ (2.26)

Statement of Changes in Shareho

Statement of Changes in Shareholders’ Equity - 12 months ended Dec. 31, 2020 - USD ($)	Class A Ordinary Shares	Class B Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019
Balance (in Shares) at Dec. 31, 2019
Issuance of Class B ordinary shares to Sponsor		$ 359	24,641		25,000
Issuance of Class B ordinary shares to Sponsor (in Shares)		3,593,750
Sale of 14,375,000 Units, less fair value of warrants	$ 1,437		140,657,938		140,659,375
Sale of 14,375,000 Units, less fair value of warrants (in Shares)	14,375,000
Underwriting discounts and offering costs, net of $186,456 allocated to the warrant liability			(8,208,498)		(8,208,498)
Excess of cash received over fair value of private placement warrants			2,473,094		2,473,094
Class A ordinary shares subject to possible redemption	$ (1,223)		(122,322,197)		(122,323,420)
Class A ordinary shares subject to possible redemption (in Shares)	(12,232,342)
Net loss				(7,625,541)	(7,625,541)
Balance at Dec. 31, 2020	$ 214	$ 359	$ 12,624,978	$ (7,625,541)	$ 5,000,010
Balance (in Shares) at Dec. 31, 2020	2,142,658	3,593,750

Statement of Changes in Share_2

Statement of Changes in Shareholders’ Equity (Parentheticals)	12 Months Ended
	Dec. 31, 2020USD ($)
Statement of Stockholders' Equity [Abstract]
Sale of Units, less fair value of warrants	$ 14,375,000
Underwriting discounts and offering costs	$ 186,456

Statement of Cash flows

Statement of Cash flows	12 Months Ended
	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (7,625,541)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation cost paid by Sponsor in exchange for issuance of founder shares	1,707
Interest earned on marketable securities held in Trust Account	(65,744)
Change in fair value of derivative warrant liability	7,193,729
Warrant issuance transaction costs	186,456
Changes in operating assets and liabilities:
Prepaid expenses	(75,844)
Accrued expenses	81,485
Net cash used in operating activities	(303,752)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(143,750,000)
Net cash used in investing activities	(143,750,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	140,875,000
Proceeds from sale of Private Placement Warrants	4,375,000
Proceeds from promissory note – related party	10,000
Repayment of promissory note – related party	(246,330)
Payments of offering costs	(229,081)
Net cash provided by financing activities	144,784,589
Net Change in Cash	730,837
Cash – Beginning
Cash – Ending	730,837
Non-Cash Investing and Financing Activities:
Initial classification of Class A ordinary shares subject to possible redemption	112,226,290
Change in value of ordinary shares subject to possible redemption	10,097,130
Offering costs paid directly by Sponsor from proceeds of issuance of Class B ordinary shares	25,000
Deferred underwriting fee payable	5,031,250
Payment of offering costs through promissory note	$ 234,623

Description of Organization and

Description of Organization and Business Operations	12 Months Ended
	Dec. 31, 2020
Description of Organization and Business Operations [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Malacca Straits Acquisition Company Limited (formerly known as Bilbao Street Limited; the “Company”) was incorporated in the Cayman Islands on July 17, 2019. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company changed its name to Malacca Straits Acquisition Company Limited on February 26, 2020. While the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus its search on businesses which are currently part of Southeast Asian business conglomerates in the media, food processing, renewable energy and healthcare industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. All activity through December 31, 2020 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on July 14, 2020. On July 17, 2020, the Company consummated the Initial Public Offering of 12,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), generating gross proceeds of $125,000,000 which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per warrant in a private placement to Malacca Straits Management Company Limited (the “Sponsor”), generating gross proceeds of $4,000,000, which is described in Note 5. Following the closing of the Initial Public Offering on July 17, 2020, an amount of $125,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States, which has been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend the Amended and Restated Memorandum and Articles of Association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete its initial Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity and (iii) the redemption of all of the Public Shares if the Company is unable to complete its initial Business Combination within the Combination Period (as defined below), subject to applicable law. On July 21, 2020, the underwriters exercised their over-allotment option in full, resulting in an additional 1,875,000 Units issued for an aggregate amount of $18,750,000. In connection with the underwriters’ exercise of their over-allotment option, the Company also consummated the sale of an additional 375,000 Private Placement Warrants at $1.00 per Private Placement Warrant, generating total proceeds of $375,000. A total of $18,750,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $143,750,000. Transaction costs amounted to $8,394,954, consisting of $2,875,000 of underwriting fees, $5,031,250 of deferred underwriting fees and $488,704 of other offering costs. Transaction costs of $186,456 attributable to the warrants were expensed. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of the stock exchange that the Company will list its securities on will require that the Company’s initial Business Combination must be with one or more target businesses that have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the Company signing a definitive agreement in connection with the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide the holders of its issued and outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and net of taxes payable), divided by the number of then issued and outstanding Public Shares. The per-share amount to be distributed to public shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and after payment of underwriters’ fees and commissions or any greater net tangible asset or cash requirement which may be contained in the agreement relating to the initial Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote any Founder Shares (as defined in Note 5) and Public Shares held by it in favor of approving a Business Combination. Additionally, public shareholders may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors have agreed to waive: (i) their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of the Company’s Business Combination and (ii) their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete its initial Business Combination within the Combination Period (as defined below) (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete its initial Business Combination within the Combination Period). The Company will have until January 17, 2022 to complete a Business Combination (the “Combination Period”). If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has determined that if the Company is unable to complete a Business Combination during the Combination Period, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period. The Company intends to complete a Business Combination before the mandatory liquidation date.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	12 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 4) and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of common shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”). In connection with the audit of the Company’s financial statements for the year ended December 31, 2020, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s ordinary share. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s ordinary share if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management concluded that the Company’s Private Placement Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded the tender offer provision included in the warrant agreement fails the “classified in shareholders’ equity” criteria as contemplated by ASC Section 815-40-25. As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash. The impact of the restatement on the balance sheets, statements of operations and statements of cash flows for the Affected Periods is presented below: As Previously Adjustments As Restated Balance sheet as of July 17, 2020 Warrant Liabilities $ - $ 4,426,385 $ 4,426,385 Total Liabilities 4,400,000 4,426,385 8,826,385 Class A Ordinary Shares Subject to Possible Redemption 116,652,678 (4,426,388 ) 112,226,290 Class A Ordinary Shares 83 45 128 Additional Paid-in Capital 5,008,176 164,242 5,172,418 Accumulated Deficit (8,617 ) (164,284 ) (172,901 ) Total Shareholders’ Equity 5,000,001 3 5,000,004 Number of Class A ordinary shares subject to redemption 11,665,268 (442,639 ) 11,222,629 As Previously Adjustments As Restated Balance sheet as of September 30, 2020 (unaudited) Warrant Liabilities $ - $ 4,647,311 $ 4,647,311 Total Liabilities 5,037,682 4,647,311 9,684,993 Class A Ordinary Shares Subject to Possible Redemption 134,692,560 (4,647,310 ) 130,045,250 Class A Ordinary Shares 91 46 137 Additional Paid-in Capital 5,062,036 (158,811 ) 4,903,225 Retained Earnings (Accumulated Deficit) (62,478 ) 158,764 96,286 Total Shareholders’ Equity 5,000,008 (1 ) 5,000,007 Number of Class A ordinary shares subject to redemption 13,469,256 (464,731 ) 13,004,525 As Previously Adjustments As Restated Balance sheet as of December 31, 2020 (audited) Warrant Liabilities $ - $ 12,186,260 $ 12,186,260 Total Liabilities 5,112,735 12,186,260 17,298,995 Class A Ordinary Shares Subject to Possible Redemption 134,509,680 (12,186,260 ) 122,323,420 Class A Ordinary Shares 92 122 214 Additional Paid-in Capital 5,244,915 7,380,063 12,624,978 Accumulated Deficit (244,356 ) 7,869,897 7,625,541 Total Shareholders’ Equity 5,000,010 - 5,000,010 Number of Class A ordinary shares subject to redemption 13,450,968 (1,218,626 ) 12,232,342 As Previously Adjustments As Restated Statement of Operations for the three months ended September 30, 2020 (unaudited) Change in fair value of warrant liability $ - $ 345,220 $ 345,220 Transaction costs allocated to issuance of warrants - (186,456 ) (186,456 ) Net income (loss) (54,366 ) 158,764 104,398 Basic and diluted income (loss) per share, Class B ordinary shares (0.02 ) 0.04 0.02 As Previously Adjustments As Restated Statement of Operations for the nine months ended September 30, 2020 (unaudited) Change in fair value of warrant liability $ - $ 345,220 $ 345,220 Transaction costs allocated to issuance of warrants - (186,456 ) (186,456 ) Net income (loss) (62,478 ) 158,764 96,286 Basic and diluted income (loss) per share, Class B ordinary shares (0.03 ) 0.05 0.02 As Previously Adjustments As Restated Statement of operations for the year ended December 31, 2020 (audited) Change in fair value of warrant liability $ - $ (7,193,729 ) $ (7,193,729 ) Transaction costs allocated to issuance of warrants - (186,456 ) (186,456 ) Net loss (245,356 ) (7,380,185 ) (7,625,541 ) Basic and diluted income (loss) per share, Class B ordinary shares (0.09 ) (2.17 ) (2.26 ) As Previously Adjustments As Restated Statement of Cash Flows for the nine months ended September 30, 2020 (unaudited) Net income (loss) $ (62,478 ) $ 158,764 $ 96,286 Change in fair value of warrant liability - (345,220 ) (345,220 ) Transaction costs allocated to issuance of warrants 186,456 186,456 Net cash used in operating activities (217,596 ) - (217,596 ) As Previously Adjustments As Restated Statement of Cash Flows for the year ended December 31, 2020 (audited) Net loss $ (245,356 ) $ (7,380,185 ) $ (7,625,541 ) Change in fair value of warrant liability - 7,193,729 7,193,729 Transaction costs allocated to issuance of warrants - 186,456 186,456 Net cash used in operating activities (303,752 ) - (303,752 )

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company had no activity for the period from July 17, 2019 (inception) through December 31, 2019. Accordingly, the balance sheet as of December 31, 2019, and the statements of operations and statement of cash flows for the comparative period from July 17, 2019 (inception) through December 31, 2019, are not presented. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, the 12,232,342 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Offering Costs Offering costs consist of underwriting, legal, accounting, and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounting to $8,394,954 of which $8,208,498 were charged to shareholders’ equity upon the completion of the Initial Public Offering and $186,486 of costs allocated to the warrants were charged to operations. Warrant Liability The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The Private Warrants were valued using a Modified Black Scholes Option Pricing Model and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Net Loss Per Ordinary Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The calculation of diluted loss per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, (ii) the exercise of the over-allotment option and (iii) Private Placement Warrants since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable to purchase 11,562,500 shares of Class A ordinary shares in the aggregate. The Company’s statements of operations include a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income per share, basic and diluted, for Class A redeemable ordinary shares is calculated by dividing the interest income earned on the Trust Account of approximately $66,000 for the year ended December 31, 2020 by the weighted average number of Class A redeemable ordinary shares outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for income attributable to Class A redeemable ordinary shares of approximately $66,000, by the weighted average number of Class B non-redeemable ordinary shares outstanding for the period. Class B non-redeemable ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): Year Ended Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income from Trust Account $ 65,744 Net Earnings $ 65,744 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted 14,330,357 Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 Non-Redeemable Class B Ordinary Shares Numerator: Net Loss minus Redeemable Net Earnings Net Loss $ (7,625,541 ) Redeemable Net Earnings (65,744 ) Non-Redeemable Net Loss $ (7,691,285 ) Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares Non-Redeemable Class B Ordinary Shares, Basic and Diluted 3,402,841 Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares $ (2.26 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Company coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s balance sheet, primarily due to their short-term nature. The Company invests in U.S Treasury securities with are comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2020
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 4 — INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 12,500,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). On July 21, 2020, in connection with the underwriters’ exercise of the over-allotment option in full, the Company sold an additional 1,875,000 Units at a price of $10.00 per Unit. Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8).

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 — RELATED PARTY TRANSACTIONS Founder Shares In March 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 2,875,000 Class B ordinary shares (the “Founder Shares”). In June 2020, the Company declared a share dividend of 0.25 of a share for each Class B ordinary share in issue, resulting in the Sponsor holding an aggregate of 3,593,750 Founder Shares. All shares have been retroactively stated to reflect the share dividend. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any Founder Shares until the earlier to occur of (i) one year after the completion of the Company’s Business Combination or (ii) subsequent to a Business Combination, (x) if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s Business Combination or (y) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Private Placement Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 4,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $4,000,000. On July 21, 2020, in connection with the underwriters’ exercise of the over-allotment option in full, the Sponsor purchased an additional 375,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant. The Private Placement Warrants were deemed to be derivative warrant liabilities at issuance and recorded at fair value. Amounts paid by the Sponsor in excess of the warrants fair value ($2,473,094) was treated as a capital contribution. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. Promissory Note – Related Party On March 31, 2020, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2020 or (ii) the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $246,330 was repaid upon the closing of the Initial Public Offering on July 17, 2020. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no outstanding borrowings under the Working Capital Loans. As of December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans. Related Party Website Services During the year ended December 31, 2020, the Company issued engaged a firm to provide website services. The Company’s Chief Financial Officer and Director, Stanley Wang, is a minority shareholder of the company providing such services. For the year ended December 31, 2020, the Company incurred and paid $2,995 for such services.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 — COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management is continuing to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights Pursuant to a registration rights agreement entered into on July 14, 2020, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $2,500,000 in the aggregate. As a result of the underwriters’ election to exercise their over-allotment in full on July 21, 2020, the underwriters were paid an additional cash underwriting discount of $375,000. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $5,031,250 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. A portion of such amount, not to exceed 25% of the total amount of the deferred fee held in the Trust Account, may be re-allocated or paid to unaffiliated thirds parties that assist the Company in consummating a Business Combination. The election to re-allocate or make any such payments to unaffiliated third parties will be solely at the discretion of the Company’s management team, and such unaffiliated third parties will be selected by the management team in their sole and absolute discretion.

Shareholders_ Equity

Shareholders’ Equity	12 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
SHAREHOLDERS’ EQUITY	NOTE 7 — SHAREHOLDERS’ EQUITY Preference Shares Class A Ordinary Shares Class B Ordinary Shares Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law; provided that only holders of Class B ordinary shares have the right to vote on the appointment of directors prior to the Company’s initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of all ordinary shares issued and outstanding upon completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).

Warrants

Warrants	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
WARRANTS	NOTE 8 — WARRANTS Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 12 months from the closing of the Initial Public Offering or (b) 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the Company’s Business Combination, the Company will use its best efforts to file, and within 60 business days following the Business Combination to have declared effective, a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available. Once the warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last sale price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date we send to the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 9 — FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts. At December 31, 2020, assets held in the Trust Account were comprised of $273 in cash and $143,815,471 in U.S. Treasury securities. During the year ended December 31, 2020, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. The gross holding gains and fair value of held-to-maturity securities at December 31, 2020 are as follows: Held-To-Maturity Level Amortized Gross Fair December 31, 2020 U.S. Treasury Securities (Mature on 1/12/2021) 1 $ 143,815,471 $ 2,091 $ 143,817,562 The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. The fair value of the derivative warrant liabilities at December 31, 2020 are as follows: Description Level Fair Derivative Warrant Liabilities – Public Warrants 1 $ 7,546,875 Derivative Warrant Liabilities – Private Placement Warrants 3 4,639,385 $ 12,186,260 The fair value of the derivative warrant liabilities at September 30, 2020 are as follows: Description Level Fair Derivative Warrant Liabilities – Public Warrants 1 $ 2,875,000 Derivative Warrant Liabilities – Private Placement Warrants 3 1,772,311 $ 4,647,311 The fair value of the derivative warrant liabilities at July 21, 2020 are as follows: Description Level Fair Derivative Warrant Liabilities – Public Warrants 3 $ 3,090,625 Derivative Warrant Liabilities – Private Placement Warrants 3 1,901,906 $ 4,992,531 The fair value of the derivative warrant liabilities at July 17, 2020 are as follows: Description Level Fair Derivative Warrant Liabilities – Public Warrants 3 $ 2,687,500 Derivative Warrant Liabilities – Private Placement Warrants 3 1,738,885 $ 4,426,385 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within derivative warrant liabilities on the Company’s balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statement of operations. Initial Measurement Public Warrants The Warrants were valued as of July 17, 2020 and July 21, 2020 (over-allotment exercise) using a Monte Carlo simulation, which is considered to be a Level 3 fair value measurement. The Monte Carlo simulation’s primary unobservable input utilized in determining the fair value of the Warrants is the probability adjusted volatility considering the probability of consummation of a Business Combination. The probability adjusted volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units is classified as Level 1 due to the use of an observable market quote in an active market. The key inputs into the Monte Carlo simulation model for the Public Warrants were as follows at initial measurement: Input Initial Risk-free interest rate 0.36 % Expected term (years) .75 Expected volatility 11.3 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00 At issuance, the Public Warrants were determined to be $0.43 per warrant. Initial Measurement – Private Warrants The Private Placement Warrants were valued using a Modified Black Scholes Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes Model uses a Black Scholes Option Pricing Model that is modified to reduce the value of the Private Placement Warrants for a discount on the lack of marketability of the instrument as well as for the probability of consummation of the Business Combination. The primary unobservable inputs utilized in determining the fair value of the Private Placement Warrants is the discount for lack of marketability and the probability of consummation of the Business Combination. The probability assigned to the consummation of the Business Combination was 80% which was determined based on a hybrid approach of both observed success rates of business combinations for special purpose acquisition companies and the Sponsors’ track record for consummating similar transactions. The key inputs into the Modified Black Scholes Model for the Private Warrants were as follows at initial measurement: Input Initial Expected term (years) 0.75 Expected volatility 10.0 % Risk-free interest rate 0.36 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00 The key inputs into the Modified Black Scholes Model for the Private Warrants were as follows at September 30, 2020: Input September 30, Expected term (years) 0.65 Expected volatility 10.0 % Risk-free interest rate 0.34 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00 The key inputs into the Modified Black Scholes Model for the Private Warrants were as follows at December 31, 2020: Input December 31, Expected term (years) 0.52 Expected volatility 15.0 % Risk-free interest rate 0.34 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00 Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement beginning on August 6, 2020, as the Public Warrants were separately listed and traded The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the year ended December 31, 2020 is summarized as follows: Public Warrants Private Warrants Total Warrants Derivative warrant liabilities at January 1, 2020 $ — — $ — July 17, 2020 Issuance of Public and Private Warrants, Level 3 inputs 2,687,500 1,738,885 4,426,385 July 21, 2020 Issuance of Public and Private Warrants, Level 3 inputs 403,125 163,021 566,461 Change in fair value of derivative warrant liabilities — (129,595 ) (129,595 ) Transfer of Public Warrants to Level 1 (3,090,625 ) — (3,090,625 ) Derivative warrant liabilities – Level 3, at September 30, 2020 — 1,772,311 1,772,311 Change in fair value of Private Warrants — 2,867,074 2,867,074 Derivative warrant liabilities – Level 3, at December 31, 2020 — 4,639,385 $ 4,639,385

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On March 22, 2021, the Company issued a press release announcing the execution of a definitive Business Combination Agreement, dated as of March 21, 2021 (the “Business Combination Agreement”), with PT Asia Vision Network, an Indonesian limited liability company (“AVN”) and indirect 99.99% owned subsidiary of PT MNC Vision Networks TBK (“MNC Group”), an Indonesian public limited liability company, and new holding company for Vision+, Indonesia’s fastest growing OTT business and MNC Play, the 3rd largest broadband and IPTV operator in Indonesia. Pursuant to the Business Combination Agreement, subject to the terms and conditions set forth therein, a newly-formed Cayman Islands subsidiary of AVN will merge with and into Malacca, with Malacca surviving the merger as a wholly-owned subsidiary of AVN, and with AVN becoming the successor US-listed company to Malacca. It is anticipated that, following the business combination, AVN’s American Depositary Receipts (“ADRs”) representing ordinary shares and AVN’s warrants to acquire ADRs will be listed on NASDAQ. In the merger, outstanding securities of Malacca Straits will be replaced by replacement securities of AVN, with the replacement AVN ordinary shares being held by The Bank of New York Mellon as the depository, and with the Bank of New York Mellon delivering ADRs of AVN to Malacca Straits’ security holders. Each Malacca Straits shareholder will receive an ADR representing one AVN ordinary share in exchange for each MLAC ordinary share that they hold; and each Malacca Straits warrant will become a warrant to purchase one ADR. MNC Group will roll 100% of its equity in AVN, and will receive additional AVN ordinary shares in connection with the merger so that when combined with its existing shares, it will own a number of shares reflecting a pre-money enterprise value of AVN of $530 million, subject to certain purchase price adjustments and indemnification obligations, with each AVN ordinary share valued at the price per share paid to each Malacca Straits public shareholder who redeems their MLAC shares in connection with the business combination. The consummation of the transaction is subject to the accuracy of the respective parties’ representations and warranties, the approval of the transaction and related matters by Malacca Straits’ shareholders and the other closing conditions set forth in the business combination agreement. The transaction has no minimum cash closing condition. The board of directors of AVN and Malacca Straits have each unanimously approved the business combination which is expected to close in late Q2 or early Q3 2021. Please refer to the 8-K filing on March 22, 2021 for more information related to the Business Combination Agreement. For additional information regarding the Business Combination and the Merger Agreement and related agreements, see the Current Report on Form 8-K filed by the Company with the SEC on March 25, 2021.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company had no activity for the period from July 17, 2019 (inception) through December 31, 2019. Accordingly, the balance sheet as of December 31, 2019, and the statements of operations and statement of cash flows for the comparative period from July 17, 2019 (inception) through December 31, 2019, are not presented.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, the 12,232,342 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Offering Costs	Offering Costs Offering costs consist of underwriting, legal, accounting, and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounting to $8,394,954 of which $8,208,498 were charged to shareholders’ equity upon the completion of the Initial Public Offering and $186,486 of costs allocated to the warrants were charged to operations.
Warrant Liability	Warrant Liability The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The Private Warrants were valued using a Modified Black Scholes Option Pricing Model and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date.
Income Taxes	Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The calculation of diluted loss per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, (ii) the exercise of the over-allotment option and (iii) Private Placement Warrants since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants are exercisable to purchase 11,562,500 shares of Class A ordinary shares in the aggregate. The Company’s statements of operations include a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income per share, basic and diluted, for Class A redeemable ordinary shares is calculated by dividing the interest income earned on the Trust Account of approximately $66,000 for the year ended December 31, 2020 by the weighted average number of Class A redeemable ordinary shares outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for income attributable to Class A redeemable ordinary shares of approximately $66,000, by the weighted average number of Class B non-redeemable ordinary shares outstanding for the period. Class B non-redeemable ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): Year Ended Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income from Trust Account $ 65,744 Net Earnings $ 65,744 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted 14,330,357 Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 Non-Redeemable Class B Ordinary Shares Numerator: Net Loss minus Redeemable Net Earnings Net Loss $ (7,625,541 ) Redeemable Net Earnings (65,744 ) Non-Redeemable Net Loss $ (7,691,285 ) Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares Non-Redeemable Class B Ordinary Shares, Basic and Diluted 3,402,841 Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares $ (2.26 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Company coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s balance sheet, primarily due to their short-term nature. The Company invests in U.S Treasury securities with are comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Schedule of the restatement on each financial statement	As Previously Adjustments As Restated Balance sheet as of July 17, 2020 Warrant Liabilities $ - $ 4,426,385 $ 4,426,385 Total Liabilities 4,400,000 4,426,385 8,826,385 Class A Ordinary Shares Subject to Possible Redemption 116,652,678 (4,426,388 ) 112,226,290 Class A Ordinary Shares 83 45 128 Additional Paid-in Capital 5,008,176 164,242 5,172,418 Accumulated Deficit (8,617 ) (164,284 ) (172,901 ) Total Shareholders’ Equity 5,000,001 3 5,000,004 Number of Class A ordinary shares subject to redemption 11,665,268 (442,639 ) 11,222,629 As Previously Adjustments As Restated Balance sheet as of September 30, 2020 (unaudited) Warrant Liabilities $ - $ 4,647,311 $ 4,647,311 Total Liabilities 5,037,682 4,647,311 9,684,993 Class A Ordinary Shares Subject to Possible Redemption 134,692,560 (4,647,310 ) 130,045,250 Class A Ordinary Shares 91 46 137 Additional Paid-in Capital 5,062,036 (158,811 ) 4,903,225 Retained Earnings (Accumulated Deficit) (62,478 ) 158,764 96,286 Total Shareholders’ Equity 5,000,008 (1 ) 5,000,007 Number of Class A ordinary shares subject to redemption 13,469,256 (464,731 ) 13,004,525 As Previously Adjustments As Restated Balance sheet as of December 31, 2020 (audited) Warrant Liabilities $ - $ 12,186,260 $ 12,186,260 Total Liabilities 5,112,735 12,186,260 17,298,995 Class A Ordinary Shares Subject to Possible Redemption 134,509,680 (12,186,260 ) 122,323,420 Class A Ordinary Shares 92 122 214 Additional Paid-in Capital 5,244,915 7,380,063 12,624,978 Accumulated Deficit (244,356 ) 7,869,897 7,625,541 Total Shareholders’ Equity 5,000,010 - 5,000,010 Number of Class A ordinary shares subject to redemption 13,450,968 (1,218,626 ) 12,232,342
Schedule of statements of operations	As Previously Adjustments As Restated Statement of Operations for the three months ended September 30, 2020 (unaudited) Change in fair value of warrant liability $ - $ 345,220 $ 345,220 Transaction costs allocated to issuance of warrants - (186,456 ) (186,456 ) Net income (loss) (54,366 ) 158,764 104,398 Basic and diluted income (loss) per share, Class B ordinary shares (0.02 ) 0.04 0.02 As Previously Adjustments As Restated Statement of Operations for the nine months ended September 30, 2020 (unaudited) Change in fair value of warrant liability $ - $ 345,220 $ 345,220 Transaction costs allocated to issuance of warrants - (186,456 ) (186,456 ) Net income (loss) (62,478 ) 158,764 96,286 Basic and diluted income (loss) per share, Class B ordinary shares (0.03 ) 0.05 0.02 As Previously Adjustments As Restated Statement of operations for the year ended December 31, 2020 (audited) Change in fair value of warrant liability $ - $ (7,193,729 ) $ (7,193,729 ) Transaction costs allocated to issuance of warrants - (186,456 ) (186,456 ) Net loss (245,356 ) (7,380,185 ) (7,625,541 ) Basic and diluted income (loss) per share, Class B ordinary shares (0.09 ) (2.17 ) (2.26 )
Schedule of statements of cash flows	As Previously Adjustments As Restated Statement of Cash Flows for the nine months ended September 30, 2020 (unaudited) Net income (loss) $ (62,478 ) $ 158,764 $ 96,286 Change in fair value of warrant liability - (345,220 ) (345,220 ) Transaction costs allocated to issuance of warrants 186,456 186,456 Net cash used in operating activities (217,596 ) - (217,596 ) As Previously Adjustments As Restated Statement of Cash Flows for the year ended December 31, 2020 (audited) Net loss $ (245,356 ) $ (7,380,185 ) $ (7,625,541 ) Change in fair value of warrant liability - 7,193,729 7,193,729 Transaction costs allocated to issuance of warrants - 186,456 186,456 Net cash used in operating activities (303,752 ) - (303,752 )

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of basic and diluted net loss per ordinary share	Year Ended Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income from Trust Account $ 65,744 Net Earnings $ 65,744 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted 14,330,357 Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 Non-Redeemable Class B Ordinary Shares Numerator: Net Loss minus Redeemable Net Earnings Net Loss $ (7,625,541 ) Redeemable Net Earnings (65,744 ) Non-Redeemable Net Loss $ (7,691,285 ) Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares Non-Redeemable Class B Ordinary Shares, Basic and Diluted 3,402,841 Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares $ (2.26 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of fair value of held-to-maturity securities	Held-To-Maturity Level Amortized Gross Fair December 31, 2020 U.S. Treasury Securities (Mature on 1/12/2021) 1 $ 143,815,471 $ 2,091 $ 143,817,562
Schedule of derivative warrant liabilities	Description Level Fair Derivative Warrant Liabilities – Public Warrants 1 $ 7,546,875 Derivative Warrant Liabilities – Private Placement Warrants 3 4,639,385 $ 12,186,260 Description Level Fair Derivative Warrant Liabilities – Public Warrants 1 $ 2,875,000 Derivative Warrant Liabilities – Private Placement Warrants 3 1,772,311 $ 4,647,311 Description Level Fair Derivative Warrant Liabilities – Public Warrants 3 $ 3,090,625 Derivative Warrant Liabilities – Private Placement Warrants 3 1,901,906 $ 4,992,531 Description Level Fair Derivative Warrant Liabilities – Public Warrants 3 $ 2,687,500 Derivative Warrant Liabilities – Private Placement Warrants 3 1,738,885 $ 4,426,385
Schedule of monte carlo simulation model for the public warrants	Input Initial Risk-free interest rate 0.36 % Expected term (years) .75 Expected volatility 11.3 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00 Input Initial Expected term (years) 0.75 Expected volatility 10.0 % Risk-free interest rate 0.36 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00 Input September 30, Expected term (years) 0.65 Expected volatility 10.0 % Risk-free interest rate 0.34 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00 Input December 31, Expected term (years) 0.52 Expected volatility 15.0 % Risk-free interest rate 0.34 % Exercise price $ 11.50 Fair value of the ordinary share price $ 10.00
Schedule of change in the fair value of the derivative warrant liabilities	Public Warrants Private Warrants Total Warrants Derivative warrant liabilities at January 1, 2020 $ — — $ — July 17, 2020 Issuance of Public and Private Warrants, Level 3 inputs 2,687,500 1,738,885 4,426,385 July 21, 2020 Issuance of Public and Private Warrants, Level 3 inputs 403,125 163,021 566,461 Change in fair value of derivative warrant liabilities — (129,595 ) (129,595 ) Transfer of Public Warrants to Level 1 (3,090,625 ) — (3,090,625 ) Derivative warrant liabilities – Level 3, at September 30, 2020 — 1,772,311 1,772,311 Change in fair value of Private Warrants — 2,867,074 2,867,074 Derivative warrant liabilities – Level 3, at December 31, 2020 — 4,639,385 $ 4,639,385

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)	1 Months Ended		12 Months Ended
	Jul. 21, 2020	Jul. 17, 2020	Dec. 31, 2020
Description of Organization and Business Operations (Details) [Line Items]
Percentage of redeem public shares		100.00%
Bringing aggregate proceeds	$ 143,750,000
Transaction costs			$ 8,394,954
Underwriting fees			2,875,000
Deferred underwriting fees			5,031,250
Other offering costs			$ 488,704
Percentage of fair market value			80.00%
Percentage of business combination			50.00%
Interest public shares (in Dollars per share)			$ 10
Net tangible assets least			$ 5,000,001
Percentage of public shares			15.00%
Interest dissolution expenses			$ 100,000
Public offering price per Unit (in Dollars per share)			$ (10)
Trust account per public share (in Dollars per share)			$ 10
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Initial public offering (in Shares)		12,500,000
Amount of net proceeds from sale of units		$ 125,000,000
Net proceeds per share (in Dollars per share)		$ 10
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Underwriters exercised	1,875,000
Issued of aggregate amount	18,750,000
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of additional	$ 375,000
Shares issued price per share (in Dollars per share)	$ 1
Generating total proceeds	$ 375,000
Deposit of trust account	$ 18,750,000
Warrant [Member]
Description of Organization and Business Operations (Details) [Line Items]
Transaction costs			$ 186,456
Percentage of business combination			180.00%
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of stock, Description			Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per warrant in a private placement to Malacca Straits Management Company Limited (the “Sponsor”), generating gross proceeds of $4,000,000, which is described in Note 5.

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details)	12 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Outstanding share percentage	50.00%

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of the restatement on each financial statement - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Jul. 17, 2020
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liabilities
Total Liabilities	5,112,735	5,037,682	4,400,000
Class A Ordinary Shares Subject to Possible Redemption	134,509,680	134,692,560	116,652,678
Class A Ordinary Shares	92	91	83
Additional Paid-in Capital	5,244,915	5,062,036	5,008,176
Retained Earnings (Accumulated Deficit)	(244,356)	(62,478)	(8,617)
Total Shareholders’ Equity	5,000,010	5,000,008	5,000,001
Number of Class A ordinary shares subject to redemption	13,450,968	13,469,256	11,665,268
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liabilities	12,186,260	4,647,311	4,426,385
Total Liabilities	12,186,260	4,647,311	4,426,385
Class A Ordinary Shares Subject to Possible Redemption	(12,186,260)	(4,647,310)	(4,426,388)
Class A Ordinary Shares	122	46	45
Additional Paid-in Capital	7,380,063	(158,811)	164,242
Retained Earnings (Accumulated Deficit)	7,869,897	158,764	(164,284)
Total Shareholders’ Equity		(1)	3
Number of Class A ordinary shares subject to redemption	(1,218,626)	(464,731)	(442,639)
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liabilities	12,186,260	4,647,311	4,426,385
Total Liabilities	17,298,995	9,684,993	8,826,385
Class A Ordinary Shares Subject to Possible Redemption	122,323,420	130,045,250	112,226,290
Class A Ordinary Shares	214	137	128
Additional Paid-in Capital	12,624,978	4,903,225	5,172,418
Retained Earnings (Accumulated Deficit)	7,625,541	96,286	(172,901)
Total Shareholders’ Equity	5,000,010	5,000,007	5,000,004
Number of Class A ordinary shares subject to redemption	$ 12,232,342	$ 13,004,525	$ 11,222,629

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of operations - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Condensed Income Statements, Captions [Line Items]
Change in fair value of warrant liability
Transaction costs allocated to issuance of warrants
Net income (loss)	$ (54,366)	$ (62,478)	$ (245,356)
Basic and diluted income (loss) per share, Class B ordinary shares (in Dollars per share)	$ (0.02)	$ (0.03)	$ (0.09)
Adjustments [Member]
Condensed Income Statements, Captions [Line Items]
Change in fair value of warrant liability	$ 345,220	$ 345,220	$ (7,193,729)
Transaction costs allocated to issuance of warrants	(186,456)	(186,456)	(186,456)
Net income (loss)	$ 158,764	$ 158,764	$ (7,380,185)
Basic and diluted income (loss) per share, Class B ordinary shares (in Dollars per share)	$ 0.04	$ 0.05	$ (2.17)
As Restated [Member]
Condensed Income Statements, Captions [Line Items]
Change in fair value of warrant liability	$ 345,220	$ 345,220	$ (7,193,729)
Transaction costs allocated to issuance of warrants	(186,456)	(186,456)	(186,456)
Net income (loss)	$ 104,398	$ 96,286	$ (7,625,541)
Basic and diluted income (loss) per share, Class B ordinary shares (in Dollars per share)	$ 0.02	$ 0.02	$ (2.26)

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of cash flows - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income (loss)	$ (54,366)	$ (62,478)	$ (245,356)
Change in fair value of warrant liability
Transaction costs allocated to issuance of warrants
Net cash used in operating activities		(217,596)	(303,752)
Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income (loss)	158,764	158,764	(7,380,185)
Change in fair value of warrant liability		(345,220)	7,193,729
Transaction costs allocated to issuance of warrants		186,456	186,456
Net cash used in operating activities
As Restated [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income (loss)	$ 104,398	96,286	(7,625,541)
Change in fair value of warrant liability		(345,220)	7,193,729
Transaction costs allocated to issuance of warrants		186,456	186,456
Net cash used in operating activities		$ (217,596)	$ (303,752)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2020USD ($)shares
Summary of Significant Accounting Policies (Details) [Line Items]
Offering costs amount	$ 8,394,954
Charged to shareholder's equity	8,208,498
Warrants changed to operations	186,486
Interest Income on trust account	66,000
Amount of federal depository insurance coverage	$ 250,000
Class A ordinary shares [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Ordinary shares subject possible redemption (in Shares) | shares	12,232,342
Class A ordinary shares [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Purchase of shares (in Shares) | shares	11,562,500
Dividing the net loss	$ 66,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net loss per ordinary share	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares
Interest Income from Trust Account	$ 65,744
Net Earnings	$ 65,744
Denominator: Weighted Average Redeemable Class A Ordinary Shares
Redeemable Class A Ordinary Shares, Basic and Diluted (in Shares) | shares	14,330,357
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares (in Dollars per share) | $ / shares	$ 0
Numerator: Net Loss minus Redeemable Net Earnings
Net Loss	$ (7,625,541)
Redeemable Net Earnings	(65,744)
Non-Redeemable Net Loss	$ (7,691,285)
Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares
Non-Redeemable Class B Ordinary Shares, Basic and Diluted (in Shares) | shares	3,402,841
Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares (in Dollars per share) | $ / shares	$ (2.26)

Initial Public Offering (Detail

Initial Public Offering (Details) - $ / shares	1 Months Ended	12 Months Ended
	Jul. 21, 2020	Dec. 31, 2020
Initial Public Offering (Details) [Line Items]
Price per share unit	$ 10
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock, units (in Shares)		12,500,000
Price per share unit		$ 10
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Number of additional units sold (in Shares)	1,875,000
Warrant [Member]
Initial Public Offering (Details) [Line Items]
Common stock price per shares		$ 11.50

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	1 Months Ended		3 Months Ended	12 Months Ended
	Jul. 17, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2020
Related Party Transactions (Details) [Line Items]
Adjusted for stock splits, per share (in Dollars per share)				$ 12
Description of private placement				the Sponsor purchased 4,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $4,000,000. On July 21, 2020, in connection with the underwriters’ exercise of the over-allotment option in full, the Sponsor purchased an additional 375,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant. The Private Placement Warrants were deemed to be derivative warrant liabilities at issuance and recorded at fair value. Amounts paid by the Sponsor in excess of the warrants fair value ($2,473,094) was treated as a capital contribution. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8).
Aggregate principal amount			$ 300,000
Outstanding amount of promissory note	$ 246,330
Services paid				$ 2,995
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Amount of sponsor paid			$ 25,000
Shares consideration (in Shares)		3,593,750
Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Shares consideration (in Shares)			2,875,000
Dividend [Member]
Related Party Transactions (Details) [Line Items]
Share price (in Dollars per share)		$ 0.25
Private Placement Warrant [Member]
Related Party Transactions (Details) [Line Items]
Description of business combination				The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no outstanding borrowings under the Working Capital Loans.

Commitments and Contingencies (

Commitments and Contingencies (Details)	12 Months Ended
	Dec. 31, 2020shares
Proposed Public Offering Shares [Member]
Commitments and Contingencies (Details) [Line Items]
Underwriting agreement description	The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $2,500,000 in the aggregate. As a result of the underwriters’ election to exercise their over-allotment in full on July 21, 2020, the underwriters were paid an additional cash underwriting discount of $375,000. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $5,031,250 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. A portion of such amount, not to exceed 25% of the total amount of the deferred fee held in the Trust Account, may be re-allocated or paid to unaffiliated thirds parties that assist the Company in consummating a Business Combination
Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Proposed public offering to purchase	2,500,000

Shareholders_ Equity (Details)

Shareholders’ Equity (Details)	12 Months Ended
	Dec. 31, 2020$ / sharesshares
Shareholders’ Equity (Details) [Line Items]
Preferred stock, shares authorized	1,000,000
Preferred stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Issued and outstanding shares of public offering, percentage	20.00%
Class A Ordinary Shares [Member]
Shareholders’ Equity (Details) [Line Items]
Ordinary stock, shares authorized	200,000,000
Ordinary shares, par value (in Dollars per share) | $ / shares	$ 0.0001
Ordinary stock, shares issued	2,142,658
Ordinary shares subject to possible redemption	12,232,342
Common stock, shares outstanding	2,142,658
Class B Ordinary Shares [Member]
Shareholders’ Equity (Details) [Line Items]
Ordinary stock, shares authorized	20,000,000
Ordinary shares, par value (in Dollars per share) | $ / shares	$ 0.0001
Ordinary stock, shares issued	3,593,750
Common stock, shares outstanding	3,593,750

Warrants (Details)

Warrants (Details)	12 Months Ended
	Dec. 31, 2020$ / shares
Warrants (Details) [Line Items]
Public warrants maturity period	5 years
Total equity proceeds, percentage	50.00%
Market value per share	$ 9.20
Market value, percentage	115.00%
Newly issued price per share	$ 18
Public warrants redemption, description	Once the warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last sale price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date we send to the notice of redemption to the warrant holders.
Warrant [Member]
Warrants (Details) [Line Items]
Total equity proceeds, percentage	180.00%
Class A Ordinary Shares [Member]
Warrants (Details) [Line Items]
Business combination, price per share	$ 9.20
Total equity proceeds, percentage	60.00%

Fair Value Measurements (Detail

Fair Value Measurements (Details)	Dec. 31, 2020USD ($)$ / shares
Fair Value Measurements (Details) [Line Items]
Fair value of price per warrant (in Dollars per share) | $ / shares	$ 0.43
Consumption of business combination percentage	80.00%
U.S. Treasury Securities [Member]
Fair Value Measurements (Details) [Line Items]
Assets held in the trust account	$ 143,815,471
Cash [Member]
Fair Value Measurements (Details) [Line Items]
Assets held in the trust account	$ 273

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of fair value of held-to-maturity securities - U.S. Treasury Securities [Member]	12 Months Ended
	Dec. 31, 2020USD ($)
Fair Value Measurements (Details) - Schedule of fair value of held-to-maturity securities [Line Items]
Held-To-Maturity	U.S. Treasury Securities (Mature on 1/12/2021)
Amortized Cost	$ 143,815,471
Gross Holding Gain	2,091
Fair Value	$ 143,817,562

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of derivative warrant liabilities - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Jul. 21, 2020	Jul. 17, 2020
Fair Value Measurements (Details) - Schedule of derivative warrant liabilities [Line Items]
Warrant Liabilities	$ 12,186,260	$ 4,647,311	$ 4,992,531	$ 4,426,385
Level 1 [Member]
Fair Value Measurements (Details) - Schedule of derivative warrant liabilities [Line Items]
Warrant Liabilities – Public Warrants	7,546,875	2,875,000
Level 3 [Member]
Fair Value Measurements (Details) - Schedule of derivative warrant liabilities [Line Items]
Warrant Liabilities – Public Warrants			3,090,625	2,687,500
Warrant Liabilities – Private Placement Warrants	$ 4,639,385	$ 1,772,311	$ 1,901,906	$ 1,738,885

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of monte carlo simulation model for the public warrants - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
Monte Carlo simulation model [Member]
Fair Value Measurements (Details) - Schedule of monte carlo simulation model for the public warrants [Line Items]
Risk-free interest rate	0.34%	0.34%
Expected term (years)	237 days	189 days
Expected volatility	10.00%	15.00%
Exercise price	$ 11.50	$ 11.50
Fair value of the ordinary share price	$ 10	$ 10
Private Warrants [Member] | Modified Black Scholes Model initial measurement [Member]
Fair Value Measurements (Details) - Schedule of monte carlo simulation model for the public warrants [Line Items]
Risk-free interest rate		0.36%
Expected term (years)		9 months
Expected volatility		10.00%
Exercise price		$ 11.50
Fair value of the ordinary share price		$ 10
Public Warrants [Member] | Monte Carlo simulation model [Member]
Fair Value Measurements (Details) - Schedule of monte carlo simulation model for the public warrants [Line Items]
Risk-free interest rate		0.36%
Expected term (years)		9 months
Expected volatility		11.30%
Exercise price		$ 11.50
Fair value of the ordinary share price		$ 10

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative warrant liabilities - Level 3 [Member] - USD ($)	3 Months Ended	9 Months Ended
	Dec. 31, 2020	Sep. 30, 2020
Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative warrant liabilities [Line Items]
Derivative warrant liabilities at beginning	$ 1,772,311
July 17, 2020 Issuance of Public and Private Warrants, Level 3 inputs		4,426,385
July 21, 2020 Issuance of Public and Private Warrants, Level 3 inputs		566,461
Change in fair value of derivative warrant liabilities		(129,595)
Transfer of Public Warrants to Level 1		(3,090,625)
Derivative warrant liabilities at ending	4,639,385	1,772,311
Change in fair value of Private Warrants	2,867,074
Private Warrants [Member]
Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative warrant liabilities [Line Items]
Derivative warrant liabilities at beginning	1,772,311
July 17, 2020 Issuance of Public and Private Warrants, Level 3 inputs		1,738,885
July 21, 2020 Issuance of Public and Private Warrants, Level 3 inputs		163,021
Change in fair value of derivative warrant liabilities		(129,595)
Transfer of Public Warrants to Level 1
Derivative warrant liabilities at ending	4,639,385	1,772,311
Change in fair value of Private Warrants	2,867,074
Public Warrants [Member]
Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative warrant liabilities [Line Items]
Derivative warrant liabilities at beginning
July 17, 2020 Issuance of Public and Private Warrants, Level 3 inputs		2,687,500
July 21, 2020 Issuance of Public and Private Warrants, Level 3 inputs		403,125
Change in fair value of derivative warrant liabilities
Transfer of Public Warrants to Level 1		(3,090,625)
Derivative warrant liabilities at ending
Change in fair value of Private Warrants

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] $ in Millions	1 Months Ended
	Mar. 22, 2021USD ($)
Subsequent Events (Details) [Line Items]
Percentage of owned subsidiary	99.99%
Percentage of equity in AVN	100.00%
Pre-money enterprise value (in Dollars)	$ 530